BC Innovations | Nov 13, 2014
Cover Story

Boosting adjuvants

For all the talk of new vaccines, not much attention has been paid to the need for better adjuvants, which have remained stuck on alum-based products for decades. The NIH is committing up to $70...
BioCentury | Oct 20, 2014
Product Development

Walking the toll road

Even after a series of clinical setbacks in the mid-2000s cooled investor and pharma interest in the once white-hot field of toll-like receptors, several companies continued toiling away. Now the spark may be rekindling as...
BC Week In Review | Oct 6, 2014
Company News

Vaxine, GlaxoSmithKline, NIH infectious news

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded five-year contracts to Vaxine, GlaxoSmithKline's Corixa Corp. unit and five research institutions developing new vaccine adjuvants that boost responses by activating the adaptive immune system....
BC Extra | Oct 1, 2014
Politics & Policy

NIAID funds development of new vaccine adjuvants

NIH's National Institute of Allergy and Infectious Diseases awarded five-year contracts to seven research institutions developing new vaccine adjuvants that boost responses by activating the adaptive immune system. The agency said total funding for all...
BioCentury | Mar 25, 2013
Finance

Done with biotech

Done with biotech Three Arch Partners has made only a handful of biotech investments since its formation in 1993, and it is not looking for any more. The VC said last week it has no...
BC Extra | Oct 9, 2009
Politics & Policy

NIAID awards $60 million for adjuvant research

NIH's National Institute of Allergy and Infectious Diseases awarded six research contracts totaling $60 million over five years to discover vaccine adjuvants. The Corixa Corp. unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) received one of the...
BC Innovations | Apr 16, 2009
Targets & Mechanisms

Toll gate against allergic asthma

Marketed treatments for allergic asthma, including corticosteroids and adrenergic receptor b2 agonists, have focused on intervening downstream from the initial inhalation of an allergen. Now, a team of Belgian and American researchers has proposed treating...
BC Week In Review | Jun 30, 2008
Company News

Immune Design Co. management update

Immune Design Co. , Seattle, Wash.   Business: Infectious   Hired: Steven Reed as CEO, formerly CSO of Corixa Corp. , now part of GlaxoSmithKline plc  ...
BC Extra | Jun 25, 2008
Financial News

Immune Design raises $18 million

Immune Design (Seattle, Wash.) raised $18 million in a series A round co-led by Alta Partners; The Column Group (TCG); and Versant Ventures. The newco will focus on developing prophylactic and therapeutic vaccines for infectious...
BioCentury | Feb 18, 2008
Emerging Company Profile

VentiRx: 8 is great

In the wake of some high-profile disappointments among compounds targeting toll-like receptors 7 and 9, VentiRx Pharmaceuticals Inc. has placed its bets on a TLR8 program. The company believes the downstream expression patterns of TLR8...
Items per page:
1 - 10 of 460
BC Innovations | Nov 13, 2014
Cover Story

Boosting adjuvants

For all the talk of new vaccines, not much attention has been paid to the need for better adjuvants, which have remained stuck on alum-based products for decades. The NIH is committing up to $70...
BioCentury | Oct 20, 2014
Product Development

Walking the toll road

Even after a series of clinical setbacks in the mid-2000s cooled investor and pharma interest in the once white-hot field of toll-like receptors, several companies continued toiling away. Now the spark may be rekindling as...
BC Week In Review | Oct 6, 2014
Company News

Vaxine, GlaxoSmithKline, NIH infectious news

NIH's National Institute of Allergy and Infectious Diseases (NIAID) awarded five-year contracts to Vaxine, GlaxoSmithKline's Corixa Corp. unit and five research institutions developing new vaccine adjuvants that boost responses by activating the adaptive immune system....
BC Extra | Oct 1, 2014
Politics & Policy

NIAID funds development of new vaccine adjuvants

NIH's National Institute of Allergy and Infectious Diseases awarded five-year contracts to seven research institutions developing new vaccine adjuvants that boost responses by activating the adaptive immune system. The agency said total funding for all...
BioCentury | Mar 25, 2013
Finance

Done with biotech

Done with biotech Three Arch Partners has made only a handful of biotech investments since its formation in 1993, and it is not looking for any more. The VC said last week it has no...
BC Extra | Oct 9, 2009
Politics & Policy

NIAID awards $60 million for adjuvant research

NIH's National Institute of Allergy and Infectious Diseases awarded six research contracts totaling $60 million over five years to discover vaccine adjuvants. The Corixa Corp. unit of GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) received one of the...
BC Innovations | Apr 16, 2009
Targets & Mechanisms

Toll gate against allergic asthma

Marketed treatments for allergic asthma, including corticosteroids and adrenergic receptor b2 agonists, have focused on intervening downstream from the initial inhalation of an allergen. Now, a team of Belgian and American researchers has proposed treating...
BC Week In Review | Jun 30, 2008
Company News

Immune Design Co. management update

Immune Design Co. , Seattle, Wash.   Business: Infectious   Hired: Steven Reed as CEO, formerly CSO of Corixa Corp. , now part of GlaxoSmithKline plc  ...
BC Extra | Jun 25, 2008
Financial News

Immune Design raises $18 million

Immune Design (Seattle, Wash.) raised $18 million in a series A round co-led by Alta Partners; The Column Group (TCG); and Versant Ventures. The newco will focus on developing prophylactic and therapeutic vaccines for infectious...
BioCentury | Feb 18, 2008
Emerging Company Profile

VentiRx: 8 is great

In the wake of some high-profile disappointments among compounds targeting toll-like receptors 7 and 9, VentiRx Pharmaceuticals Inc. has placed its bets on a TLR8 program. The company believes the downstream expression patterns of TLR8...
Items per page:
1 - 10 of 460